483 3D Imaging Drug Design and Development Sep 2014

483 3D Imaging Drug Design and Development Sep 2014

Charles Brown FDA$119.00 - Available Now

FDA investigators audited the 3D Imaging Drug Design and Development - Little Rock, AR, United States facility and issued 6 inspectional observations (via FDA 483) on 05 Sep 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 6
  • Inspection end: 05 Sep 2014
  • Location: Little Rock, United States
  • FEI: 3009143510
Add To Cart